Recent News

• 12.19.2025 - Galectin Therapeutics Provides Regulatory Update Following FDA Written Response and Announces an Additional $10 Million Line of Credit from Richard E. Uihlein Sufficient to Cover Expected Expenditures Through March 2027

Recent Filings

• 12.17.2025 - 144 Report of proposed sale of securities
• 12.17.2025 - 144 Report of proposed sale of securities
• 12.17.2025 - 144 Report of proposed sale of securities
• 12.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.15.2025 - 144/A Report of proposed sale of securities
• 12.15.2025 - 144 Report of proposed sale of securities
• 12.12.2025 - 144 Report of proposed sale of securities
• 12.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.09.2025 - 144 Report of proposed sale of securities
• 12.08.2025 - 8-K Current report